Submitted by Anonymous (not verified) on 9 April 2025 - 13:24
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 7, Status: Authorised